Capital Flow Monitor · Sponsors · CIK 2145477
Avoro Ventures Fund II L.P.
110 GREENE STREET, NEW YORK, NY, 10012 · (212) 037-4970
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | D ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- - Avoro Ventures GP LLC — Executive Officer, New York, NY
-
Behzad Aghazadeh — Executive Officer, New York, NY
2 other raises
- Avoro Life Sciences Offshore Fund Ltd. $2.18B of —
- Avoro Life Sciences Fund LLC $3.45B of —
-
Scott Epstein — Executive Officer, New York, NY
2 other raises
- Avoro Life Sciences Offshore Fund Ltd. $2.18B of —
- Avoro Life Sciences Fund LLC $3.45B of —
-
Neil Cammarosano — Executive Officer, New York, NY
2 other raises
- Avoro Life Sciences Offshore Fund Ltd. $2.18B of —
- Avoro Life Sciences Fund LLC $3.45B of —
- - Avoro Ventures LLC — Promoter, New York, NY
-
- Avoro Capital GP, LLC — Promoter, New York, NY
2 other raises
- Avoro Life Sciences Offshore Fund Ltd. $2.18B of —
- Avoro Life Sciences Fund LLC $3.45B of —
-
- Avoro Capital L.P. — Promoter, New York, NY
2 other raises
- Avoro Life Sciences Offshore Fund Ltd. $2.18B of —
- Avoro Life Sciences Fund LLC $3.45B of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.